Search

Author/Creator Corless, Christopher L.

1. A case of recurrent epilepsy‐associated rosette‐forming glioneuronal tumor with anaplastic transformation in the absence of therapy. Issue 5 (21st August 2019)

Authors:
Halfpenny, Aaron; Ferris, Sean P.; Grafe, Marjorie; Woltjer, Randy; Selden, Nathan; Nazemi, Kellie; Perry, Arie; Solomon, David A.; Gultekin, Sakir H.; Moore, Stephen; Olson, Susan; Lawce, Helen; Lucas, Lora; Corless, Christopher L.; Wood, Matthew D.
Journal:
Neuropathology
Issue:
Volume 39:Issue 5(2019)
Page Start:
389
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago "1, 200 Patients Project". Issue 1 (10th March 2014)

Authors:
O'Donnell, Peter H.; Danahey, Keith; Jacobs, Michael; Wadhwa, Nisha R.; Yuen, Shennin; Bush, Angela; Sacro, Yasmin; Sorrentino, Matthew J.; Siegler, Mark; Harper, William; Warrick, Andrea; Das, Soma; Saner, Don; Corless, Christopher L.; Ratain, Mark J.; Williams, Marc S.
Journal:
American journal of medical genetics
Issue:
Volume 166:Issue 1(2014)
Page Start:
68
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour. (July 2016)

Authors:
Wagner, Andrew J.; Agulnik, Mark; Heinrich, Michael C.; Mahadevan, Daruka; Riedel, Richard F.; von Mehren, Margaret; Trent, Jonathan; Demetri, George D.; Corless, Christopher L.; Yule, Murray; Lyons, John F.; Oganesian, Aram; Keer, Harold
Journal:
European journal of cancer
Issue:
Volume 61(2016)
Page Start:
94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Dose-escalation study of a second-generation non-ansamycin HSP90 inhibitor, onalespib (AT13387), in combination with imatinib in patients with metastatic gastrointestinal stromal tumour. (July 2016)

Authors:
Wagner, Andrew J.; Agulnik, Mark; Heinrich, Michael C.; Mahadevan, Daruka; Riedel, Richard F.; von Mehren, Margaret; Trent, Jonathan; Demetri, George D.; Corless, Christopher L.; Yule, Murray; Lyons, John F.; Oganesian, Aram; Keer, Harold
Journal:
European journal of cancer
Issue:
Volume 61(2016)
Page Start:
94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3-Mutated Metastatic Breast Cancer. (2021)

Authors:
Parmar, Swapnil; Keck, Jamie M.; Kong, Ben; Look, Regan; Johnson, Brett; Patterson, Janice; Labrie, Marilyne; Guimaraes, Alexander R.; Corless, Christopher L.; Beadling, Carol; Kolodzie, Annette; Bergan, Raymond; Gray, Joe W.; Mills, Gordon B.; Mitri, Zahi I.
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Exceptional Response to Trastuzumab in a Heavily Pretreated Patient With ERBB3‐Mutated Metastatic Breast Cancer. (December 2021)

Authors:
Parmar, Swapnil; Keck, Jamie M.; Kong, Ben; Look, Regan; Johnson, Brett; Patterson, Janice; Labrie, Marilyne; Guimaraes, Alexander R.; Corless, Christopher L.; Beadling, Carol; Kolodzie, Annette; Bergan, Raymond; Gray, Joe W.; Mills, Gordon B.; Mitri, Zahi I.
Journal:
JCO precision oncology
Issue:
Volume 5(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. (26th November 2013)

Authors:
Misemer, Benjamin S.; Skubitz, Amy P. N.; Carlos Manivel, J.; Schmechel, Stephen C.; Cheng, Edward Y.; Henriksen, Jonathan C.; Koopmeiners, Joseph S.; Corless, Christopher L.; Skubitz, Keith M.
Journal:
Cancer medicine
Issue:
Volume 3:Number 1(2014:Feb.)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. (26th November 2013)

Authors:
Misemer, Benjamin S.; Skubitz, Amy P. N.; Carlos Manivel, J.; Schmechel, Stephen C.; Cheng, Edward Y.; Henriksen, Jonathan C.; Koopmeiners, Joseph S.; Corless, Christopher L.; Skubitz, Keith M.
Journal:
Cancer medicine
Issue:
Volume 3:Number 1(2014:Feb.)
Page Start:
81
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. GAB1‐ABL1 fusions in tumors that have histologic overlap with NTRK‐rearranged spindle cell tumors. Issue 9 (10th June 2021)

Authors:
Choo, Florence; Rakheja, Dinesh; Davis, Lara E.; Davare, Monika; Park, Jason Y.; Timmons, Charles F.; Neff, Tanaya; Beadling, Carol; Corless, Christopher L.; Davis, Jessica L.
Journal:
Genes, chromosomes & cancer
Issue:
Volume 60:Issue 9(2021)
Page Start:
623
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗